Zelnorm (tegaserod) is back, but only for certain patients
Zelnorm (tegaserod) is back, but only for certain patients.
It's for women under 55 with chronic idiopathic constipation or irritable bowel syndrome with constipation who haven't responded to other treatments...or who were helped with Zelnorm in the past.
And these patients can't be at risk for cardiovascular disease.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote